Related references
Note: Only part of the references are listed.Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model
L. Tanner et al.
NATURE COMMUNICATIONS (2023)
Mirtazepine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
Rasha Abdelhady et al.
BIOMEDICINE & PHARMACOTHERAPY (2023)
LncRNA TUG1 promotes pulmonary fibrosis progression via up-regulating CDC27 and activating PI3K/Akt/mTOR pathway
Fei Qi et al.
EPIGENETICS (2023)
Sparganii Rhizoma alleviates pulmonary fibrosis by inhibiting fibroblasts differentiation and epithelial-mesenchymal transition mediated by TGF-β1/ Smad2/3 pathway
Jing Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2023)
Pulmonary fibrosis model of mice induced by different administration methods of bleomycin
Aman Gul et al.
BMC PULMONARY MEDICINE (2023)
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need
Mona H. Zohny et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
An overview of post COVID sequelae
Ajay Kumar Shukla et al.
Journal of Basic and Clinical Physiology and Pharmacology (2022)
Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis
Andrew Achaiah et al.
BMJ OPEN RESPIRATORY RESEARCH (2022)
CEMIP (HYBID, KIAA1199): structure, function and expression in health and disease
Sofia Spataro et al.
FEBS JOURNAL (2022)
Immune dysregulation as a driver of idiopathic pulmonary fibrosis
Kevin Shenderov et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review)
Zhimin Ye et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response
Willis S. Bowman et al.
FRONTIERS IN MEDICINE (2021)
Micellar Hyaluronidase and Spiperone as a Potential Treatment for Pulmonary Fibrosis
Evgenii Skurikhin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis
Giacomo Sgalla et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Biosynthesis, characterization and evaluation of the supportive properties and biocompatibility of DBM nanoparticles on a tissue-engineered nerve conduit from decellularized sciatic nerve
Faezeh Nasrollahi nia et al.
Regenerative Therapy (2020)
The importance of interventional timing in the bleomycin model of pulmonary fibrosis
Philipp Kolb et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Hyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells
Laura Pandolfi et al.
MOLECULES (2019)
Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms
Nanda Gamad et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP)
Ulrich Costabel et al.
RESPIRATION (2017)
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
Lisa H. Lancaster et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Nigella sativa, a traditional Tunisian herbal medicine, attenuates bleomycin-induced pulmonary fibrosis in a rat model
Anouar Abidi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis
R. Gisli Jenkins et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
Role and New Insights of Pirfenidone in Fibrotic Diseases
David Alejandro Lopez-de la Mora et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)
Correlation of hyaluronan deposition with infiltration of eosinophils and lymphocytes in a cockroach-induced murine model of asthma
Georgiana Cheng et al.
GLYCOBIOLOGY (2013)
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis
Claudia S. Bitencourt et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis
Amber L. Degryse et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)
Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
Curtis B. Thompson et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Hyaluronan Orchestrates Transforming Growth Factor-β1-dependent Maintenance of Myofibroblast Phenotype
Jason Webber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma
Maud M. Gueders et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Snake venom hyaluronidase: a therapeutic target
K Kemparaju et al.
CELL BIOCHEMISTRY AND FUNCTION (2006)
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects
LA Ortiz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)